While Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) still rule the weight-loss drug market with their respective GLP-1 medications, competition could soon be heating up as rival products near ...
ABC News’ Alexis Christoforous breaks down reactions from investors over the job market, interest rates and the effects of the California wildfires on the economy.